Clinical trial
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
NCT02537483 is registered in ClinicalTrials.gov with Valeant Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
- Lead sponsor
- Valeant Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- September 30, 2016
- Enrollment
- 350 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.